Sinopharm Group Co. Ltd. (SHTDY)
USD 13.79
(0.0%)
USD 13.79
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 383.39 Billion CNY | 5.1% |
| 2022 | 364.77 Billion CNY | 8.75% |
| 2021 | 335.41 Billion CNY | 7.77% |
| 2020 | 311.23 Billion CNY | 15.32% |
| 2019 | 269.88 Billion CNY | 14.47% |
| 2018 | 235.77 Billion CNY | 39.07% |
| 2017 | 169.53 Billion CNY | 7.5% |
| 2016 | 157.71 Billion CNY | 14.06% |
| 2015 | 138.26 Billion CNY | 7.47% |
| 2014 | 128.65 Billion CNY | 22.0% |
| 2013 | 105.45 Billion CNY | 32.07% |
| 2012 | 79.84 Billion CNY | 18.07% |
| 2011 | 67.62 Billion CNY | 60.96% |
| 2010 | 42.01 Billion CNY | 48.59% |
| 2009 | 28.27 Billion CNY | 75.46% |
| 2008 | 16.11 Billion CNY | 12.79% |
| 2007 | 14.28 Billion CNY | 23.27% |
| 2006 | 11.59 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 429.58 Billion CNY | 4.0% |
| 2024 Q1 | 413.06 Billion CNY | 7.74% |
| 2023 Q3 | 419.94 Billion CNY | 0.54% |
| 2023 FY | 383.39 Billion CNY | 5.1% |
| 2023 Q4 | 383.39 Billion CNY | -8.7% |
| 2023 Q2 | 417.69 Billion CNY | 3.93% |
| 2023 Q1 | 401.9 Billion CNY | 10.18% |
| 2022 Q2 | 370.17 Billion CNY | 2.67% |
| 2022 FY | 364.77 Billion CNY | 8.75% |
| 2022 Q3 | 386.82 Billion CNY | 4.5% |
| 2022 Q4 | 364.77 Billion CNY | -5.7% |
| 2022 Q1 | 360.55 Billion CNY | 7.5% |
| 2021 Q4 | 335.41 Billion CNY | -4.28% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q3 | 350.42 Billion CNY | 1.77% |
| 2021 FY | 335.41 Billion CNY | 7.77% |
| 2021 Q2 | 344.33 Billion CNY | 0.0% |
| 2020 Q3 | 324.19 Billion CNY | 5.83% |
| 2020 Q2 | 306.33 Billion CNY | 1.85% |
| 2020 Q1 | 300.75 Billion CNY | 11.44% |
| 2020 FY | 311.23 Billion CNY | 15.32% |
| 2020 Q4 | 311.23 Billion CNY | -4.0% |
| 2019 Q1 | 255.89 Billion CNY | 8.54% |
| 2019 Q2 | 274.48 Billion CNY | 7.26% |
| 2019 Q3 | 287 Billion CNY | 4.56% |
| 2019 Q4 | 269.88 Billion CNY | -5.96% |
| 2019 FY | 269.88 Billion CNY | 14.47% |
| 2018 Q2 | 191.82 Billion CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 FY | 235.77 Billion CNY | 39.07% |
| 2018 Q4 | 235.77 Billion CNY | 0.0% |
| 2017 Q3 | 190.69 Billion CNY | 9.81% |
| 2017 Q4 | 169.53 Billion CNY | -11.09% |
| 2017 FY | 169.53 Billion CNY | 7.5% |
| 2017 Q2 | 173.65 Billion CNY | 0.0% |
| 2017 Q1 | 173.65 Billion CNY | 10.11% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 157.71 Billion CNY | 0.0% |
| 2016 Q3 | 157.71 Billion CNY | 3.39% |
| 2016 Q2 | 152.53 Billion CNY | 0.0% |
| 2016 FY | 157.71 Billion CNY | 14.06% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 138.26 Billion CNY | 7.47% |
| 2015 Q3 | 139.42 Billion CNY | 2.28% |
| 2015 Q2 | 136.32 Billion CNY | 0.0% |
| 2015 Q4 | 138.26 Billion CNY | -0.83% |
| 2014 Q1 | 113.17 Billion CNY | 7.32% |
| 2014 Q4 | 128.65 Billion CNY | 0.0% |
| 2014 FY | 128.65 Billion CNY | 22.0% |
| 2014 Q3 | 128.65 Billion CNY | 13.68% |
| 2014 Q2 | 113.17 Billion CNY | 0.0% |
| 2013 Q2 | 97.38 Billion CNY | 0.0% |
| 2013 Q1 | 97.38 Billion CNY | 21.97% |
| 2013 FY | 105.45 Billion CNY | 32.07% |
| 2013 Q4 | 105.45 Billion CNY | 0.0% |
| 2013 Q3 | 105.45 Billion CNY | 8.28% |
| 2012 FY | 79.84 Billion CNY | 18.07% |
| 2012 Q2 | 75.51 Billion CNY | 0.0% |
| 2012 Q4 | 79.84 Billion CNY | 0.0% |
| 2011 FY | 67.62 Billion CNY | 60.96% |
| 2011 Q4 | 67.62 Billion CNY | 0.0% |
| 2011 Q2 | 58.16 Billion CNY | 0.0% |
| 2010 FY | 42.01 Billion CNY | 48.59% |
| 2010 Q4 | 42.01 Billion CNY | 0.0% |
| 2010 Q2 | 35.39 Billion CNY | 0.0% |
| 2009 FY | 28.27 Billion CNY | 75.46% |
| 2009 Q4 | 28.27 Billion CNY | 0.0% |
| 2009 Q2 | 18.77 Billion CNY | 0.0% |
| 2008 Q4 | 16.11 Billion CNY | 0.0% |
| 2008 FY | 16.11 Billion CNY | 12.79% |
| 2007 FY | 14.28 Billion CNY | 23.27% |
| 2006 FY | 11.59 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| China Medicine Corporation | 66.84 Million USD | -573462.443% |
| DH Enchantment Inc. | 3814.00 USD | -10052303098.741% |
| Exlites Holdings International, Inc. | 445.71 Thousand USD | -86018029.114% |
| Itonis, Inc. | 92.35 Thousand USD | -415140549.465% |
| One Step Vending Corp. | 580.16 Thousand USD | -66084001.337% |
| MediPal Holdings Corporation | 11.88 Billion USD | -3125.374% |
| PD-Rx Pharmaceuticals, Inc. | 12.95 Million USD | -2960423.994% |
| Pharmagen, Inc. | 1282.30 USD | -29898997326.499% |
| Suzuken Co., Ltd. | 8.11 Billion USD | -4622.816% |